Massachusetts Life Sciences Center invests
$4.6 million to enhance cell manufacturing core
We are pleased to announce that NCC Scientific Advisory Board member, Dr. Jerome Ritz, Executive Director of the Connell and O'Reilly Families Cell Manipulation Core Facility, is leading a major expansion and relocation of the facility, made possible by a $4.6 million dollar grant awarded by the Massachusetts Life Sciences Center.
"Cellular therapies are the 'next big thing' in cancer therapy. The first cancer cell therapy was approved by the FDA last month and there is now a lot of exciting research in this area. In the next few years, cellular therapies will also be applied to other diseases. The new lab will allow us to be in the forefront of this type of basic and clinical research," says Dr. Ritz.
Read more HERE
Dr. Bigner on a recent segment of CBS News 60 minutes
The esteemed weekly news program “60 Minutes” on CBS aired an in-depth story (two segments – which is rare for “60 Minutes”) on a potential new treatment for glioblastoma multiforme.
The segment followed brain cancer patients in a Duke University clinical trial of a therapy that uses a re-engineered polio virus to kill cancer cells.
If you did not get a chance to watch the segment now, we highly encourage you to do so. You can view the entire episode (along with some extras!) here.
It was very encouraging to see the unique opportunities and challenges in treating a difficult cancer like GBM highlighted by such a prominent national news outlet. And the results from this early clinical trial certainly appear promising. However, it is important to note that the trial is still in Phase 1 and the treatment has only been given to a small number of patients. Stay tuned for a forthcoming post that explores more the state of this and other promising clinical research.
Support the National Cancer Center by Using Amazon Smile
AgGressive Cancer Research
The Aggressive Cancer Research program of NCC specializes in fundraising for colon cancer, ovarian cancer, and prostate cancer.
The Breast Cancer Project
The Breast Cancer Project specifically funds grants focusing on breast and research and prevention. The program was by NCC created because breast cancer is the second leading cause of cancer deaths in women today (after lung cancer) and is the most common cancer among women, excluding non-melanoma skin cancers.
Children's Cancer Project
The Children's Cancer Project of NCC provides funds for pediatric cancer research and community education.
Fighting Childhood Leukemia
The Fighting Childhood Leukemia (FCL) program of NCC provides additional research funding for the single most common form of cancer in children, leukemia. Childhood leukemias account for more than one-third of all new cases of childhood cancers.
"The National Cancer Center fills an extremely important function in funding postdoctoral fellowships. Postdoctoral fellows are essential to conduct the cancer research of the investigators of every institution in the country. There is a significant shortage of fellowship funding and many of the applicants, are ineligible for federal funding. The National Cancer Center fills the gap to a significant extent."
Darell D. Bigner, M.D., Ph.D.
Edwin L. Jones, Jr. and Lucille Finch Jones
Cancer Research Professor
Director, Preston Robert Tisch Brain Tumor Center at Duke
Chief, Preuss Laboratory for Brain Tumor Research
"I believe that the funding of early-phase cancer research investigators, both pre-doctoral and post-doctoral, is one of the key needs we have in this time. The NCC is oriented to filling this gap, and has supported trainees in a number of critical areas of investigation."
John M. Kirkwood, MD Professor of Medicine,
Dermatology and Translational Science Co-Director,
Melanoma and Skin Cancer Program
University of Pittsburgh Cancer Institute
Hillman Cancer Outpatient Pavilion
"For those individuals who want to establish a career in cancer research, the first few years are critical as they identify scientific mentors and begin their research projects. NCC fellowship grants focus on these individuals and your rigorous selection process helps identify the most talented young investigators likely to have great impact on the field."
Jerome Ritz, MD Executive Director,
Connell O’Reilly Cell Manipulation Core Facility
Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School